Di Nuzzo Private Wealth, Inc. Catalent, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 15 shares of CTLT stock, worth $886. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$886
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTLT
# of Institutions
512Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$907 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$440 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$378 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$267 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...